한국인 투자자로서 저는 이런 제약 회사를 본 적이 없습니다. $BNCM 은 자체 자산이 상승하는 희귀한 보석 중 하나입니다. 사실을 믿지 않는 것은 망상일 것입니다.#투자 #스몰캡스톡 #BNCM #DELEX #FOMO #PennyStocks #UndervaluedOTC #Investing #SmallCapStocks #HealthcareStocks #OTCMarkets

$DELX Ticker Update! DELEX reports massive 186% growth in Specialty Hospital Portfolio! ₱48.9M Sales ₱37.3M Gross Profit. Now covering 449 hospital accounts! New ticker, new highs? $NVDA $TSLA #Stocks #PennyStocks #Investing

Strong Start. Powerful Momentum. Bright Future. $DELX (formerly $BNCM) is showing what real healthcare growth looks like 150% pre-tax income surge in Q1 2026! Don’t sleep on this OTC mover. Positioned for big gains! #OTC #PennyStocks #DELX #StocksToWatch #ViralStocks #Investing

$BNCM → $DELX rebrand complete! Delex Healthcare just dropped STRONG Q1 2026 results: 150% GROWTH in pre-tax income Exceptional profitability, building massive momentum in healthcare. This OTC gem is just getting started! #PennyStocks #OTC #Stocks #DELX #MoonShot

GOOD MORNIG !!! $DELEX #PennyStocks #OTCStocks #StockMarket #Investing #ViralStocks #MoonShot

$DELX (formerly $BNCM) exploding! 186% Specialty Hospital growth → ₱48.9M Sales ₱37.3M Profit, now at 449 accounts. Top OTC Penny Play Today: $DELX Loading up! #DELX #PennyStocks #OTC #ViralStocks

$BNCM is now $DELX! 186% growth: ₱48.9M Sales, ₱37.3M Gross Profit, 449 hospital accounts. Today’s Top OTC Penny Stock: $DELX Don’t miss this healthcare runner! #DELX #PennyStocks #OTCStocks #StocksToWatch

$SNDL $MULN $FFIE $GNS $DELX $CEI $NAKD $IDEX $NILE $HMBL $ATEN $BBIG $COSM $TTOO $BETS $TOP #PennyStocks #OTC #StocksToWatch #Trading #InvestNow #Viral

$DELX (formerly $BNCM) just rebranded and EXPLODING in healthcare! DELEX reports 186% Growth in Specialty Hospital Portfolio → ₱48.9M Sales ₱37.3M Gross Profit. Now covering 449 hospital accounts! This OTC gem is positioned for massive upside. #PennyStocks #OTCStocks

Not saying $DELX is the next runner... But I've seen enough ticker change stories to know that once volume and attention arrive, the market moves fast. Early eyes matter. $SNDL $MULN $FFIE $GNS $CEI $NAKD $IDEX $NILE $HMBL $ATER $BBIG $COSM $TTOO $BETS $TOP

#StockMarket #Stocks #Investing #Trading #Investment #Finance #OTC #OTCMkts #PennyStocks #OTCStocks #PinkSheets #DayTrading #SwingTrading #StockTrader #Trader #Investor #StocksToWatch #StockPicks #TradingTips #FinancialFreedom #WealthBuilding #TechnicalAnalysis #StockMarketNews

🚨 $DELX UPDATE DELEX just dropped its Q1 2026 results ~ and it’s a strong one. 📈 Pre-tax income up 150% year-over-year Momentum is clearly building as the company posts major financial growth this quarter. $SNDL $MULN $FFIE $GNS $CEI $NAKD $IDEX $NILE $HMBL $ATER $BBIG $COSM

$DELX Q1 2026 Highlights: Pre-tax income: 150% growth Strong operational performance Continued upward financial trajectory DELEX shows accelerating fundamentals in its latest quarterly report. $SNDL $MULN $FFIE $GNS $CEI $NAKD $IDEX $NILE $HMBL $ATER $BBIG $COSM $TTOO $BETS $TOP

FULL-LIST OF STOCKS THAT CAN RUN 50-100% NEXT OR WILL RECOVER #1 $DELX #2 $RKTO #3 $DGNX #4 $ANY #5 $NBIS #6 $STI #7 $MNTS #8 $NVTS #9 $QCLS #10 $ORBS #11 $RR #12 $OPEN #13 $BYND #14 $LASE #15 $STAK #16 $NEXR #17 $SMTK #18 $MRVL #19 $SIDU

FINAL WATCHLIST AT OPEN #1 $DELX AI HEALTHCARE #2 $PRFX #3 $MASK #4 $CMND #5 $QTEX #6 $N0W #7 $ASTC #8 $CODX #9 $VSEE #10 $MNTS $SIDU #11 $WOK $DEVS $МЕНА #12 $ELAB #13 $IOTR THEME: NANO FLOATS PENNY STOCKS SPACE THEME Al/QUANTUM TODAY IS A DAY TO STAY ONLINE

#1 $DLEX NEW TICKER SYMBOL(AI HEALTHCARE) #2 $HOTH SPACE #3 $TE #4 $VSEE SPACE #5 $ASTC SPACE #6 $NCPL #7 $IREN #8 $AIM EBOLA #9 $SNGX EBOLA #10 $MNTS SPACE #11 $SIDU SPACE otcmarkets.com/stock/DELX/qu…

$DELX is trending hard among OTC traders after the former $BNCM officially changed names and ticker. Fresh ticker. Fresh branding. Healthcare growth narrative. This is exactly the type of setup that creates massive retail buzz in the OTC market. $NVDA $MU $ASTS $RKLB $TSLA $AMD

$BNCM 10Q out. huge profit rise. A lot of interesting developments in subsequent events. Somehow OTC traders still sleep on this one. LOL. NOTE 5 – SUBSEQUENT EVENTS Business Updates as of April 15, 2026 As of April 15, 2026, Delex Pharma International, Inc. sustained strong growth and continued to execute multiple strategic initiatives in finance, operations, partnerships, and portfolio expansion. Net income before tax reached approximately $449,700 in Q1 2026, representing a 150% increase year-on-year driven by continued growth in the Critical Care, Anesthesia, and Oncology divisions. The Company also implemented strategic austerity measures in response to the 2026 oil crisis, focusing on energy efficiency, route optimization, disciplined spending, and productivity initiatives. The Company is finalizing a non-exclusive partnership with Zuellig Pharma Corporation to strengthen nationwide hospital reach, improve receivables management, and enhance distribution capabilities, with operations targeted to commence by May 2026. Delex currently operates 13 pharmacy stores strategically located near hospitals and continues to expand the Med4U retail pharmacy network to strengthen market presence and improve profitability. The Company established provincial depots in Iloilo, Cebu, Davao, Tuguegarao, Legazpi, Batangas, Kalibo, and Cagayan de Oro to improve nationwide distribution coverage and reduce lead times for emergency and critical care medicines. Finalization of Delex’s entitlement for the Philips Imaging Business has been moved to Q4 2026. In the interim, the Company was appointed as Spot Dealer for a tertiary private hospital in Bulacan under an approximately $860,00 Philips CT scan project. Delex also received entitlement as channel partner for Philips Hospital Patient Monitors under the Masimo–Philips agreement for IntelliVue modules with Rainbow Technology, with potential sales revenue expected upon FDA approval anticipated in late 2026. For Masimo (USA), CMDR draft approval has been received for ROOT with O3, Rad-97 with non-invasive blood pressure, and related platforms. Product launches are expected beginning Q2 2026 with projected revenues of not less than approximately $331,00 in 2026. The Company continues to strengthen its Continuing Medical Education initiatives through the Delex ICU Forum®, which has conducted 37 hybrid webinars providing accredited CPD units to healthcare professionals nationwide. Management expects to complete the increase in authorized capital stock from approximately $165,000 to approximately $1.65 million by Q2 2026 to strengthen the Company’s financial position and support long-term growth initiatives

$BNCM is now $DELX otcmarkets.com/stock/DELX/ne…

#StockMarket #Stocks #Investing #Trading #Investment #Finance #OTC #OTCMkts #PennyStocks #OTCStocks #PinkSheets #DayTrading #SwingTrading #StockTrader #Trader #Investor #StocksToWatch #StockPicks #TradingTips #FinancialFreedom #WealthBuilding #TechnicalAnalysis #StockMarketNews

$BNCM is now $DELX! otcmarkets.com/stock/DELX/pr…